Kit for the preparation of technetium TC 99M Sestambi Injection: Product sterility may be compromised in affected lot.
Brand(s)
Last updated
Summary
Product
Kit for the preparation of technetium TC 99M Sestambi Injection
Issue
Health products - Product safety
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Kit for the preparation of technetium TC 99M Sestambi Injection |
Kit for the preparation of technetium TC 99M Sestambi Injection |
DIN 02329794 |
Powder for solution |
TETRAKIS [CU(MIBI)4]BF4 / 1mg/vial |
092-24006C |
Issue
Product sterility may be compromised in affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Healthcare Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Curium Canada Inc..
217 & 220 2572 Boul. Daniel-Johnson,
Laval, Quebec,
H7T 2R3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-76585
Get notified
Receive emails about new and updated recall and safety alerts.